ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
DHT Cream: Have a feeling that this may generate conversation
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="MikeXL" data-source="post: 50634" data-attributes="member: 4958"><p><strong>Male sexual function can be maintained without aromatization: randomized placebo-controlled trial of dihydrotestosterone (DHT) in healthy, older men for 24 months.</strong></p><p></p><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sartorius%20GA%5BAuthor%5D&cauthor=true&cauthor_uid=24751323" target="_blank">Sartorius GA</a>[SUP]<span style="font-size: 10px">1</span>[/SUP], <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ly%20LP%5BAuthor%5D&cauthor=true&cauthor_uid=24751323" target="_blank">Ly LP</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Handelsman%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=24751323" target="_blank">Handelsman DJ</a>.</p><p></p><p></p><p></p><ul> <li data-xf-list-type="ul">[SUP]<span style="font-size: 10px">1</span>[/SUP]Andrology Department, Concord Hospital, Sydney, NSW, Australia; ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia.</li> </ul><p></p><p></p><p><strong>Abstract</strong></p><p></p><p><strong>INTRODUCTION:</strong></p><p></p><p>Male sexual function is highly androgen dependent but whether aromatization of testosterone (T) to estradiol is required remains contentious.</p><p><strong>AIM:</strong></p><p></p><p>This study aims to investigate the effects of selective estrogen deficiency induced by a nonaromatizable androgen, dihydrotestosterone (DHT), on sexual function of healthy middle-aged and older men.</p><p><strong>METHODS:</strong></p><p></p><p>Randomized clinical trial of daily transdermal DHT (70 mg) or placebo gel treatment in 114 healthy middle-aged and older (>50 years, mean 60.5 years) men without known prostate disease maintaining selective estrogen deficiency for 24 months.</p><p><strong>OUTCOME MEASURES AND ANALYSIS:</strong></p><p></p><p>The end points were responses to a psychosexual and mood questionnaire completed before, at 3 months, then at 6 monthly intervals during and 3 months after study. Data were analyzed by mixed model analysis of variance for repeated measures using age and body mass index (BMI) as covariates and including interactions of treatment with age and time-on-study.</p><p><strong>RESULTS:</strong></p><p></p><p>DHT treatment increased serum DHT with complete suppression of serum T, luteinizing hormone, follicle stimulating hormone, and estradiol throughout the 24-month study resulting in reduced spinal bone density. There were no spontaneous complaints, or discontinuations for, adverse effects on sexual function during the study. DHT administration had no effects on any of 33 measures of sexual function and mood, apart from a mild, but significant decrease in overall sexual desire, which was reversible after cessation of treatment. Increasing age and less often increasing BMI were associated with significant decreases in most aspects of sexual function.</p><p><strong>CONCLUSIONS:</strong></p><p></p><p>We conclude that aromatization plays only a minimal role in maintenance of sexual function in healthy eugonadal middle-aged or older men, but age and obesity are significantly associated with decreases in most aspects of self-reported sexual function and satisfaction. The dependence of male sexual function on aromatization may be conditional on age and obesity and can be overcome by a nonaromatizable androgen.</p><p>© 2014 International Society for Sexual Medicine.</p></blockquote><p></p>
[QUOTE="MikeXL, post: 50634, member: 4958"] [B]Male sexual function can be maintained without aromatization: randomized placebo-controlled trial of dihydrotestosterone (DHT) in healthy, older men for 24 months.[/B] [URL="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sartorius%20GA%5BAuthor%5D&cauthor=true&cauthor_uid=24751323"]Sartorius GA[/URL][SUP][SIZE=2]1[/SIZE][/SUP], [URL="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ly%20LP%5BAuthor%5D&cauthor=true&cauthor_uid=24751323"]Ly LP[/URL], [URL="http://www.ncbi.nlm.nih.gov/pubmed/?term=Handelsman%20DJ%5BAuthor%5D&cauthor=true&cauthor_uid=24751323"]Handelsman DJ[/URL]. [LIST] [*][SUP][SIZE=2]1[/SIZE][/SUP]Andrology Department, Concord Hospital, Sydney, NSW, Australia; ANZAC Research Institute, University of Sydney, Sydney, NSW, Australia. [/LIST] [B]Abstract[/B] [B]INTRODUCTION:[/B] Male sexual function is highly androgen dependent but whether aromatization of testosterone (T) to estradiol is required remains contentious. [B]AIM:[/B] This study aims to investigate the effects of selective estrogen deficiency induced by a nonaromatizable androgen, dihydrotestosterone (DHT), on sexual function of healthy middle-aged and older men. [B]METHODS:[/B] Randomized clinical trial of daily transdermal DHT (70 mg) or placebo gel treatment in 114 healthy middle-aged and older (>50 years, mean 60.5 years) men without known prostate disease maintaining selective estrogen deficiency for 24 months. [B]OUTCOME MEASURES AND ANALYSIS:[/B] The end points were responses to a psychosexual and mood questionnaire completed before, at 3 months, then at 6 monthly intervals during and 3 months after study. Data were analyzed by mixed model analysis of variance for repeated measures using age and body mass index (BMI) as covariates and including interactions of treatment with age and time-on-study. [B]RESULTS:[/B] DHT treatment increased serum DHT with complete suppression of serum T, luteinizing hormone, follicle stimulating hormone, and estradiol throughout the 24-month study resulting in reduced spinal bone density. There were no spontaneous complaints, or discontinuations for, adverse effects on sexual function during the study. DHT administration had no effects on any of 33 measures of sexual function and mood, apart from a mild, but significant decrease in overall sexual desire, which was reversible after cessation of treatment. Increasing age and less often increasing BMI were associated with significant decreases in most aspects of sexual function. [B]CONCLUSIONS:[/B] We conclude that aromatization plays only a minimal role in maintenance of sexual function in healthy eugonadal middle-aged or older men, but age and obesity are significantly associated with decreases in most aspects of self-reported sexual function and satisfaction. The dependence of male sexual function on aromatization may be conditional on age and obesity and can be overcome by a nonaromatizable androgen. © 2014 International Society for Sexual Medicine. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone Basics & Questions
DHT Cream: Have a feeling that this may generate conversation
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top